Newspaper Publication regarding special window for re-lodgement of transfer and dematerialisation request(s) of physical securities
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals has published a notice in the Financial Express (English) and Mumbai Lakshdeep (Marathi) on March 14, 2026, informing shareholders about a special one-year window to re-lodge physical share transfer and dematerialisation requests that were earlier rejected. The window runs from April 5, 2026 to April 4, 2027 and is meant for physical securities originally lodged for transfer or dematerialisation on or before April 1, 2019 but rejected and returned. Shareholders can approach the company's registrar (KFin Technologies) to resubmit their requests, get a new share certificate, or have shares credited to their demat account. The information is also available on the company's website www.ayurvedganga.com. The filing was signed by Managing Director Bharat Sharma (DIN: 00077026).
This is a routine SEBI-mandated compliance filing and does not affect the company's business or stock price. Shareholders holding old physical share certificates that were previously rejected for transfer or demat can now use this limited window to regularise their holdings.